Discover the latest news on Corganics®. For all Media/Press Inquiries, please contact: press@corganics.com.

________________________ 

March 8, 2023
Corganics, healthcare professionals' most trusted and recommended clinical cannabinoid (CBD) company, today announced a patient access partnership with OrthoLoneStar, the largest independent orthopedic practice in Texas and one of the largest in the U.S. The partnership provides OrthoLoneStar patients access to Corganics' clinical CBD therapies throughout OrthoLoneStar's locations.
Read on PR Newswire >>


August 4, 2022
Corganics, healthcare professionals' most trusted and recommended clinical cannabinoid (CBD) company, has announced their new partnership with MedResults Network (MRN), a purchasing group that provides products and services to over 3,400 aesthetic medical practices and med spas.
Read on Corganics.com >>

July 27, 2022
Corganics®, healthcare professionals' most trusted and recommended clinical cannabinoid (CBD) company, and Hair Enhancement Centers, a leading clinical provider of safe, clinically proven hair growth and health technology, announce a strategic partnership
Read on Corganics.com >>

February 23, 2022
Corganics Appoints Pharmaceutical Executive Jeff Hartness to its Board of Directors
Read on PR Newswire >>

January 21, 2022
Today we are joined by The Founders of Corganics -- Chad Collins and Reggie Gatewood. Based in the Allen location of Caddo Offices, Corganics is bridging the gap between healthcare providers and their patients when it comes to understanding the benefits of CBD.
Listen on Humans of Caddo Offices >>


December 10, 2021
MD Farma closes funding and changes name to Corganics to expand cannabinoid product lines
Read on Medical and Pharma Insider >>

December 2, 2021
Clinical CBD company lands new funding and a new name
Read on NTX Inno >>

November 30, 2021
Dallas-Based Corganics Receives Series A Funding to Accelerate Delivery of Clinical Cannabinoid Products to Healthcare Providers
Read on Dallas Innovates >>

November 30, 2021
MD Farma Closes Series A Funding and Changes Name to Corganics as the Company Expands Clinical Cannabinoid (CBD) Product Lines Sold Only in Healthcare Facilities
Read on PR Newswire >>

November 9, 2020
PODCAST: Episode 29: Make Money in Your Sleep
Listen on The Fierce Factor with Kaeli Lindholm >>